Journal
HORMONE RESEARCH IN PAEDIATRICS
Volume 74, Issue 5, Pages 305-311Publisher
KARGER
DOI: 10.1159/000320028
Keywords
Thyroid; Hyperthyroidism; Methimazole; Propylthiouracil; Radioactive iodine; Thyroidectomy; Hepatotoxicity
Categories
Ask authors/readers for more resources
Background/Aims: Graves' disease (GD) is the most common cause of thyrotoxicosis in children and adolescents. Caused by immunologic stimulation of the thyroid-stimulating hormone receptor, lasting remission occurs in only a minority of pediatric patients with GD, including children treated with antithyroid drugs (ATDs) for many years. Thus the majority of pediatric patients with GD will need thyroidectomy or treatment with radioactive iodine (RAI; I-131). Results: When ATDs are used in children, only methimazole should be used. Propylthiouracil is associated with an unacceptable risk of severe liver injury in children and should never be used as first-line therapy. If remission (defined as normal thyroid function off ATDs) is not achieved after 1 or 2 years of ATD therapy, I-131 or surgery may be considered, with the choice influenced by the age of the individual. When I-131 is used, administered doses should be >150 mu Ci/g of thyroid tissue. When surgery is performed, near total or total thyroidectomy is recommended. Conclusion: Choosing a treatment approach for childhood GD is often a difficult and highly personal decision. Discussion of the advantages and risks of each therapeutic option is essential to help the patient and family select a treatment option. Copyright (C) 2010 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available